An update from Bluejay Diagnostics ( ($BJDX) ) is now available. On December 29, 2025, Bluejay Diagnostics announced it had completed ...

Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”) announced that it has completed commercial-scale production of both polyclonal and monoclonal antibodies targeting interleukin-6 ...

ADMA Biologics, Inc. (NASDAQ:ADMA) is one of the Stocks That Could Mint Millionaires in 2026. ADMA Biologics, Inc. (NASDAQ:ADMA) markets BIVIGAM, an intravenous immune globulin product indicated for ...

Bluejay Diagnostics, Inc. (NASDAQ: BJDX) ("Bluejay" or the "Company") announced that it has completed commercial-scale production of both polyclonal and ...

Therapeutic antibodies, especially polyclonal antibodies, are indispensable in contemporary medicine for addressing a broad spectrum of conditions, including infectious diseases, autoimmune disorders, ...

Antibodies are a major component of adaptive immunity against invading pathogens. In this presentation, we will describe an analytical approach to characterize the antigen-specific antibody repertoire ...

The paper addresses the problem of optimising the mapping of serum antibody responses against a known antigen. The manuscript describes a method using EM polyclonal epitope mapping to help elucidate ...

Antibodies are the number one immune cells that fight against infection and diseases. However, beyond their natural usage, biochemistry has devised several ways in which these antibodies can be ...

Rapid Novor Inc., the world's leader in mass spectrometry (MS)-based antibody sequencing, published a peer-reviewed research article where REpAb ® antibody discovery platform was used to sequence a ...

Sarafan ChEM-H, Stanford University, Stanford, California 94305, United States Department of Biochemistry, Stanford University School of Medicine, Stanford, California 94305, United States Sarafan ...

Despite limited information regarding its clinical efficacy, polyclonal antibody treatment with SAB-185 was safe for the treatment of COVID-19 and associated with reduced time to symptom resolution ...

According to Vision Research Reports, the monoclonal antibodies market is poised to grow at a CAGR of 11.07% from 2024 to 2033. According to Vision Research Reports, the monoclonal antibodies market ...